Fully bioresorbable vascular scaffolds (BVS) are a new approach to the percutaneous treatment of coronary artery disease. The BVS have not yet been fully tested in complex lesions, including chronic total occlusion (CTO). We report a CTO case successfully treated with a second-generation bioabsorbable drug-eluting scaffold.
Rama-Merchan, J.C., Mattesini, A., Dall'Ara, G., Di Mario, C. (2014). Chronic total occlusion successfully treated with a bioresorbable everolimus-eluting vascular scaffold. POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 10(2), 128-129 [10.5114/pwki.2014.43521].
Chronic total occlusion successfully treated with a bioresorbable everolimus-eluting vascular scaffold
Dall'Ara, Gianni;
2014
Abstract
Fully bioresorbable vascular scaffolds (BVS) are a new approach to the percutaneous treatment of coronary artery disease. The BVS have not yet been fully tested in complex lesions, including chronic total occlusion (CTO). We report a CTO case successfully treated with a second-generation bioabsorbable drug-eluting scaffold.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
